The Global Epidemiology of Diabetes and Kidney Disease
Advances in Chronic Kidney Disease, ISSN: 1548-5595, Vol: 25, Issue: 2, Page: 121-132
2018
- 430Citations
- 723Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations430
- Citation Indexes429
- 429
- CrossRef170
- Policy Citations1
- Policy Citation1
- Captures723
- Readers723
- 723
- Mentions2
- News Mentions2
- News2
Most Recent News
House Veterans' Affairs Subcommittee on Health Hearing; "Iowa: A Leader in Veteran Healthcare Innovation."; Testimony by Mahsaw Mansoor, resident in the University of Iowa, Department of Ophthalmology
Chairwoman Miller-Meeks, Ranking Member Brownley, and distinguished members of the subcommittee: On behalf of the University of Iowa Healthcare and the Iowa City Veterans' Affairs
Review Description
The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S154855951730188X; http://dx.doi.org/10.1053/j.ackd.2017.10.011; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85044100927&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/29580576; https://linkinghub.elsevier.com/retrieve/pii/S154855951730188X; https://dx.doi.org/10.1053/j.ackd.2017.10.011
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know